The 60-day annual session of the West Virginia Legislature reached its halfway mark Thursday, with Republican lawmakers ...
Curasight A/S (CPH: CURAS) a clinical-stage radiopharmaceutical company pioneering first-in-class uPAR-targeted radioligand platform therapies across multiple aggressive solid tumors, will present ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results